Donate

Research

Sheba offers one of the world’s largest and best medical centers as a place to innovate and test new ideas and technologies.

Latest Research


In-House Technology Used to Expedite Delivery of CAR-T Therapy

May 10, 2023

They’ve been likened to “giving patients a living drug” against cancer cells—genetically engineered T cells that selectively identify tumor cells and become super-activated upon binding to these cells. Known as […]

Read More


Inspire Technologies Signs Agreement to Conduct Clinical Study of HYLA Blood Sensor

December 27, 2022

The agreement with Sheba Medical Center, 10th ranked hospital in the world, to be the first site for the HYLA Blood Sensor’s Clinical Study Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: […]

Read More


In a first, children with rare genetic diseases get mitochondrial transplants from their mothers

December 27, 2022

At a far distant point in Earth’s ancient past, two separate, single-celled life forms — an archaeon and a bacteria — became one in an act either of symbiosis or […]

Read More


SciSparc Announces Positive Study Results with SCI-210, a Cannabidiol-Based Treatment for Epilepsy

December 14, 2022

The non- clinical study was conducted at The Chaim Sheba Medical Center in Israel SciSparc Ltd. (Nasdaq: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to […]

Read More


Nuvo Group and Sheba Medical Center’s “Sheba BEYOND” Complete First Phase of Collaboration to Create a Virtual Obstetric Solution & Catalyze Research to Advance the Standard of Pregnancy Care

August 25, 2022

Early-stage collaboration includes the evaluation of a new virtual care regimen for managing gestational diabetes and the use of AI to develop personalized care pathways and predictive analytics Nuvo Group—the […]

Read More


Israeli researchers testing if cord blood could help treat autism

August 18, 2022

Umbilical cord blood is normally thrown away at birth. But for World Autism Awareness Day on Friday, a team of doctors and scientists are calling on new mothers to collect […]

Read More


Oral immunotherapy safe, effective for children with high-threshold peanut allergy

June 14, 2022

Fixed-dose OIT appeared safe and effective for younger children with high-threshold peanut allergy, according to a single-center, cross-sectional prospective study published in Annals of Allergy, Asthma & Immunology. Soad Haj […]

Read More


Type 1 diabetes is not always ‘juvenile,’ new Israeli study shows – exclusive

June 14, 2022

Pancreatic cells that produce insulin can be destroyed in overweight teens as well as adults, requiring injections of insulin, according to Sheba study. For many years, diabetologists have been saying […]

Read More


Race Oncology advances Zantrene AML trials at Chaim Sheba, Israel

June 1, 2022

“The positive results from the first stage of this trial in such a heavily pre-treated relapsed or refractory acute myeloid leukaemia population is encouraging, especially with three of the patients […]

Read More


Model Using Routine Clinical Data May Predict Pancreatic Cancer Risk

February 18, 2022

Findings show promise following diagnosis of impaired fasting glucose A model using routine clinical information can predict pancreatic ductal adenocarcinoma (PDA) following diagnosis of impaired fasting glucose (IFG), according to […]

Read More